AI assistant
COLLEGIUM PHARMACEUTICAL, INC — Director's Dealing 2015
May 6, 2015
32163_dirs_2015-05-06_61418b90-67fd-496f-a860-fc1c658f2440.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: COLLEGIUM PHARMACEUTICAL, INC (COLL)
CIK: 0001267565
Period of Report: 2015-05-06
Reporting Person: Kopecky Ernest A (see remarks)
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Stock Option (right to purchase) | $.48 | 2022-06-13 | Common Stock (36231) | Direct | |
| Stock Option (right to purchase) | $.48 | 2023-01-30 | Common Stock (1811) | Direct | |
| Stock Option (right to purchase) | $.28 | 2024-03-05 | Common Stock (19299) | Direct | |
| Stock Option (right to purchase) | $5.73 | 2025-03-19 | Common Stock (23429) | Direct |
Footnotes
F1: 26,418 options are exercisable. The options vest and become exercisable over a 4-year period commencing on May 30, 2012, Ernest Kopecky's date of hire. Twenty-five percent (25%) of the options vested and became exercisable on May 30, 2013, and then in equal monthly installments (rounded up to the nearest whole option) at the end of each monthly period over the remaining three years of the 4-year period.
F2: 1,056 options are exercisable. The options vest and become exercisable in equal installments (rounded up to the nearest whole option) at the end of each month over a 4-year period commencing on January 24, 2013.
F3: 5,227 options are exercisable. The options vest and become exercisable in equal installments (rounded up to the nearest whole option) on a monthly basis over a 4-year period commencing on March 5, 2014.
F4: 488 options are exercisable. The options vest and become exercisable in equal installments (rounded up to the nearest whole option) on a monthly basis over a 4-year period commencing on March 19, 2015.